Poliomyelitis in Gaza.

Autor: Gupta N; Department of Infectious Disease, Kasturba Medical College, Manipal Academy of Higher Education, Manipal, India; Emerging Infections Subcommittee, European Society of Clinical Microbiology and Infectious Disease, Basel, Switzerland., Grobusch MP; Emerging Infections Subcommittee, European Society of Clinical Microbiology and Infectious Disease, Basel, Switzerland; Center of Tropical Medicine and Travel Medicine, Department of Infectious Diseases, Amsterdam Infection and Immunity, Amsterdam Public Health, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands., Jokelainen P; Emerging Infections Subcommittee, European Society of Clinical Microbiology and Infectious Disease, Basel, Switzerland; Infectious Disease Preparedness and One Health, Statens Serum Institut, Copenhagen, Denmark., Wyllie AL; Emerging Infections Subcommittee, European Society of Clinical Microbiology and Infectious Disease, Basel, Switzerland; Department of Global, Environmental, and Occupational Health, University of Maryland School of Public Health, College Park, MD, USA., Barac A; Emerging Infections Subcommittee, European Society of Clinical Microbiology and Infectious Disease, Basel, Switzerland; Clinic for Infectious and Tropical Diseases, University Clinical Center of Serbia, University of Belgrade, Belgrade, Serbia., Mora-Rillo M; Emerging Infections Subcommittee, European Society of Clinical Microbiology and Infectious Disease, Basel, Switzerland; High-Level Isolation Unit, Infectious Diseases Unit, La Paz University Hospital, IdiPAZ, Madrid, Spain., Gkrania-Klotsas E; Emerging Infections Subcommittee, European Society of Clinical Microbiology and Infectious Disease, Basel, Switzerland; Department of Infectious Diseases, Cambridge University Hospitals & The Clinical School, University of Cambridge, Cambridge, United Kingdom., Pellejero-Sagastizabal G; Emerging Infections Subcommittee, European Society of Clinical Microbiology and Infectious Disease, Basel, Switzerland; Servicio de Enfermedades Infecciosas/Division of Infectious Diseases, Hospital Clínico Universitario Universidad de Zaragoza, Instituto de Investigación Sanitaria Aragón (IIS Aragón), Zaragoza, Spain., Paño-Pardo JR; Emerging Infections Subcommittee, European Society of Clinical Microbiology and Infectious Disease, Basel, Switzerland; Servicio de Enfermedades Infecciosas/Division of Infectious Diseases, Hospital Clínico Universitario Universidad de Zaragoza, Instituto de Investigación Sanitaria Aragón (IIS Aragón), Zaragoza, Spain., Duizer E; Emerging Infections Subcommittee, European Society of Clinical Microbiology and Infectious Disease, Basel, Switzerland; Centre for Infectious Diseases Control (CIb), National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands., Lescure FX; Emerging Infections Subcommittee, European Society of Clinical Microbiology and Infectious Disease, Basel, Switzerland; Infectious and Tropical Diseases Department, APHP, Bichat Hospital and Université Paris Cité, Inserm, Paris, France. Electronic address: xavier.lescure@aphp.fr.

Publikováno v: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases [Clin Microbiol Infect] 2024 Oct 11. Date of Electronic Publication: 2024 Oct 11.

Performance Assessment of Software to Detect and Assist Prescribers with Antimicrobial Drug Interactions: Are all of them Created Equal?

Autor: Morte-Romea E; Infectious Diseases Service, Hospital Clínico Universitario 'Lozano Blesa', 50009 Zaragoza, Spain.; Instituto de Investigación Sanitaria Aragón (IIS Aragón), 50009 Zaragoza, Spain., Luque-Gómez P; Instituto de Investigación Sanitaria Aragón (IIS Aragón), 50009 Zaragoza, Spain.; Intensive Care Unit. Hospital Clínico Universitario 'Lozano Blesa', 50009 Zaragoza, Spain., Arenere-Mendoza M; Instituto de Investigación Sanitaria Aragón (IIS Aragón), 50009 Zaragoza, Spain.; Department of Hospital Pharmacy, Hospital Clínico Universitario 'Lozano Blesa', 50009 Zaragoza, Spain., Sierra-Monzón JL; Instituto de Investigación Sanitaria Aragón (IIS Aragón), 50009 Zaragoza, Spain.; Emergency Room Department, Hospital Clínico Universitario 'Lozano Blesa', 50009 Zaragoza, Spain., Camón Pueyo A; Instituto de Investigación Sanitaria Aragón (IIS Aragón), 50009 Zaragoza, Spain.; Internal Medicine Department, Hospital Clínico Universitario 'Lozano Blesa', 50009 Zaragoza, Spain., Pellejero Sagastizabal G; Instituto de Investigación Sanitaria Aragón (IIS Aragón), 50009 Zaragoza, Spain.; Internal Medicine Department, Hospital Clínico Universitario 'Lozano Blesa', 50009 Zaragoza, Spain., Verdejo Muñoz G; Instituto de Investigación Sanitaria Aragón (IIS Aragón), 50009 Zaragoza, Spain.; Internal Medicine Department, Hospital Clínico Universitario 'Lozano Blesa', 50009 Zaragoza, Spain., Sánchez Fabra D; Instituto de Investigación Sanitaria Aragón (IIS Aragón), 50009 Zaragoza, Spain.; Internal Medicine Department, Hospital Clínico Universitario 'Lozano Blesa', 50009 Zaragoza, Spain., Paño-Pardo JR; Infectious Diseases Service, Hospital Clínico Universitario 'Lozano Blesa', 50009 Zaragoza, Spain.; Instituto de Investigación Sanitaria Aragón (IIS Aragón), 50009 Zaragoza, Spain.

Publikováno v: Antibiotics (Basel, Switzerland) [Antibiotics (Basel)] 2020 Jan 04; Vol. 9 (1). Date of Electronic Publication: 2020 Jan 04.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Optimization of Therapy and the Risk of Probiotic Use during Antibiotherapy in Septic Critically Ill Patients: A Narrative Review.

Autor: Onofrei, Maria Ioana, Ghiciuc, Cristina Mihaela, Luca, Catalina Mihaela, Postolache, Paraschiva, Sapaniuc, Cristina, Enache Leonte, Georgiana, Rosu, Florin Manuel

Publikováno v: Medicina (1010660X); Mar2023, Vol. 59 Issue 3, p478, 15p

Pharmacokinetics and Toxicokinetic Considerations - Vol II

Autor: Rakesh Kumar Tekade

Pharmacokinetics and Toxicokinetic Considerations explains the central principles, cutting-edge methodologies, and incipient thought processes applied to toxicology research. As part of the Advances in Pharmaceutical Product Development and Research